CK Life Sciences Intl (Holdings) Inc - 27 Oct 2025 SCHEDULE 13D/A Report for TransCode Therapeutics, Inc. Common Stock (RNAZ)

Filing Manager
CK Life Sciences Intl (Holdings) Inc
Reporting Manager
CK Life Sciences Int'l., (Holdings) Inc.
Security
TransCode Therapeutics, Inc. Common Stock
Symbol
RNAZ
Shares outstanding
915K shares
Disclosed Ownership
83.3K shares
Ownership
9.1%
Form type
SCHEDULE 13D/A
Filing time
28 Oct 2025, 17:39:57 UTC
Date of event
27 Oct 2025
Previous filing
16 Oct 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
CK Life Sciences Int'l., (Holdings) Inc. 9.1% 83.3K 83.3K 0 /s/ Yu Ying Choi, Alan Abel Yu Ying Choi, Alan Abel/Manager 0001297567
DEFJ, LLC 9.1% 83.3K 83.3K 0 /s/ Yu Ying Choi, Alan Abel Yu Ying Choi, Alan Abel/ Manager